Vericel
VCEL · NASDAQ
Bulios Fair Price
$23.24
39.4% downside
Trenutna cena
$38.34
Po podatkih Bulios Fair Price je delnica VCEL trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Vericel Corporation is a biotechnology company that specializes in the development and commercialization of advanced therapies for tissue regeneration. The company primarily focuses on treating severe wounds, burns, and orthopedic conditions, offering autologous cell therapies that use a patient’s own cells to support healing and regeneration. Its key products include Epicel, a therapy for burn treatment, and Carticel, a cell therapy for cartilage repair.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Dominick C. Colangelo
Employees
398
Headquarters
Burlington
Prihajajoči dogodki
Earnings
Upcoming earnings report